Robert C. Cohen

Mr. Cohen currently holds the position of Vice President and Chief Technology Officer, Global Research & Development of Stryker’s Orthopaedic Joint Replacement division. He has worked in the orthopedic medical device industry for thirty-five years and has managed research, development, manufacturing, regulatory, clinical research, quality and marketing functions. Prior to their acquisition by Stryker in 2013, Mr. Cohen held the position of Senior Vice President, Clinical and Market Development, for MAKO Surgical Corp., an orthopedic robotics company, as well as having the role of General Manager of their New Jersey implant R&D and additive-manufacturing facility. From 2007 until MAKO’s purchase of the assets in 2013 of Pipeline Biomedical, a company founded by Mr Cohen, he served as its Chief Technology Officer and Senior Vice President of R&D. From 1992 to 2004, he served as Vice President of Product Development for Implex Corp, a developer of advanced joint replacement and spinal implants fabricated from a novel porous metal biomaterial trademarked as Trabecular Metal. Following the acquisition of Implex Corp by Zimmer Inc, a large manufacturer and supplier of orthopedic implants in 2004, Mr. Cohen served as Zimmer’s General Manager of their New Jersey engineering and manufacturing operations through 2006. From 1984 to 1992, he held various engineering positions at Stryker’s joint replacement division Osteonics, including Director of Product Development. Mr. Cohen has over 25 patents and speaks globally at medical education conferences. He also serves on numerous boards and is the Vice-Chair of the Board of Trustees of the New Jersey Institute of Technology, a leading US polytechnic university with over 12,000 students. Mr. Cohen has a Bachelor of Science and a Master of Science in Mechanical Engineering and a Master of Science in Engineering Management, all from New Jersey Institute of Technology.

Stryker Orthopaedics is a New Jersey based company considered to be one of the global leaders in hip and knee joint replacement. Stryker, a public company, believes that using technology to improve patient outcomes will also contribute to its overall business growth. Mr Cohen, an NJIT graduate, leads a large research and development group that drives innovation into orthopedic surgical procedures and the medical device protheses. Mr Cohen will present the challenges in joint replacement, how technologies contribute to enhanced clinical results, and the dramatic impact this has had to recent Stryker market-segment share gains.